Quarterly report pursuant to Section 13 or 15(d)

Inventories, net (Tables)

v3.22.1
Inventories, net (Tables)
9 Months Ended
Feb. 28, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current

(in thousands)

    

February 28, 2022

    

May 31, 2021

Raw materials

$

19,517

$

28,085

Work-in-progress

 

63,151

 

65,394

Total inventories, net

$

82,668

$

93,479

Schedule of remaining shelf life of inventory

(in thousands, Expiration period ending February 28,)

    

Remaining shelf-life

    

Raw materials

    

Work-in-progress bulk drug product

    

Work-in-progress finished drug product in vials

    

Total inventories

2022

0 to 12 months

$

5,828

$

-

$

-

$

5,828

2023

13 to 24 months

16,263

-

-

16,263

2024

25 to 36 months

2,209

-

29,142

31,351

2025

37 to 48 months

888

-

32,344

33,232

2026

49 to 60 months

-

-

-

-

Thereafter

61 or more months

157

1,665

-

1,822

Total inventories

25,345

1,665

61,486

88,496

Inventories reserved

(5,828)

-

-

(5,828)

Total inventories, net

$

19,517

$

1,665

$

61,486

$

82,668